(Total Views: 271)
Posted On: 06/30/2020 1:36:09 PM
Post# of 107026
$PBIO The integrated workflow of LMD and PCT was developed by Dr. Thomas P. Conrads, a nationally acclaimed protein chemist. Dr. Conrads is the Senior Director of Women's Health Research in the Inova Women's Service Line; he is also Chief Scientific Officer of the Women's Health Integrated Research Center (WHIRC) at Inova Health System.
Dr. Conrads said: "We believe that integrating LMD, PCT, and MS will improve our understanding of the complex tissue microenvironment and better enable identification of new biomarkers. We believe that the insights gained from applying this novel workflow will result in significant improvements in the clinical management of gynecologic and other cancers."
The global cancer biomarker market is expected to reach $136.5 billion by 2023.
https://www.nasdaq.com/press-release/pressure...nce%3A-the
Dr. Conrads said: "We believe that integrating LMD, PCT, and MS will improve our understanding of the complex tissue microenvironment and better enable identification of new biomarkers. We believe that the insights gained from applying this novel workflow will result in significant improvements in the clinical management of gynecologic and other cancers."
The global cancer biomarker market is expected to reach $136.5 billion by 2023.
https://www.nasdaq.com/press-release/pressure...nce%3A-the
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
